The global demand for Left Atrial Appendage Closure Device Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Left atrial appendage closure device helps prevent stroke by sealing off a small, unnecessary section of the heart called the left atrial appendage. The device is effective at eliminating the possibility of blood collecting in the left atrial appendage. The device is implanted by surgery. There are different LAA closure devices implanted by various methods performed under general anaesthesia, meaning the patient is asleep during the whole procedure. Device help can be achieved from an outside perspective or an inside blood exposed device.
Stroke is a serious risk for patients with atrial fibrillation. Patients with atrial fibrillation are at a higher danger of stroke if not appropriately treated. Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world. The growing prevalence of atrial fibrillation will be driving the growth of the market. Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market. However, implantation of an LAA occluder device also entails short-term and long-term risks. Also, device implantation procedures do not totally eliminate the possibility of blood clots which is hampering the growth of the market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of left atrial appendage closure device.
The entire left atrial appendage closure device market has been sub-categorized into product and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By End User
- Epicardial LAA Closure Device
- Endocardial LAA Closure Device
- Ambulatory Surgical Centers
- Heart Clinics
This section covers regional segmentation which accentuates on current and future demand for left atrial appendage closure device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Left Atrial Appendage Closure Device Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.